Publications
5891 Results
- Journal / Conference
- Prostate Jun;77(8):908-919
- Year
- 2017
- Research Committee(s)
- Cancer Control
- PMID
- PMID28317149
- PMC
- PMC5400704
- Study Number(s)
- SWOG-9217
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial
- Journal / Conference
- JAMA Oncology Oct 1;3(10):1345-1351
- Year
- 2017
- Research Committee(s)
- Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lung, Lymphoma, Multiple sites, and Myeloma
- PMID
- PMID28586789; PMC5710507
- Study Number(s)
- S0226, SWOG-7436, SWOG-7704/05, SWOG-7817, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8591(NCI Intergroup #0035), SWOG-8624, SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8736 (INT-0093), SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-8814, SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817), SWOG-8897, SWOG-8949, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9126, SWOG-9210, SWOG-9308, S9916
The effect of positive SWOG treatment trials on survival of patients with cancer in the US population
- Journal / Conference
- Journal of Comparative Effectiveness Research Jul;6(5):461-470. Epub 2017 Jul 7
- Year
- 2017
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID28686055
- PMC
- PMC5827800
- Study Number(s)
- S1415CD
A Stakeholder-Informed Randomized, Controlled Comparative Effectiveness Study of an Order Prescribing Intervention to Improve Colony Stimulating Factor use for Cancer Patients Receiving Myelosuppressive Chemotherapy: The TrACER Study
- Journal / Conference
- Journal of Urology Mar;197(3 Pt 1):538-540; Epub 2016 Dec 16
- Year
- 2017
- Research Committee(s)
- Genitourinary
- PMID
- PMID27992750
- PMC
- PMC n/a - editorial
- Study Number(s)
- S1602
Bacillus Calmette-Gue'rin manufacturing and SWOG S1602 Intergroup clinical trial [editorial]
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 529); American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9313
Impact of DNA repair deficiency signature on outcomes in triple negative breast cancer (TNBC) patients treated with AC chemotherapy (SWOG S9313)
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 521); American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
SWOG S0221 Updated: Comparison of two schedules of paclitaxel as adjuvant therapy for breast cancer
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 519); American Society of Clinical Oncology (ASCO) Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion
- Year
- 2017
- Research Committee(s)
- Breast
- Study Number(s)
- S0800
Effects of neoadjuvant chemotherapy (NAC) on tumor infiltrating lymphocytes (TIL) and PD-L1 expression in the SWOG S0800 clinical trial
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr e18311); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017Chicago, IL), publish only
- Year
- 2017
- Research Committee(s)
- Cancer Care Delivery
Impact of value of information analyses on SWOG’s clinical trial capsule scoring
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 6542); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Cancer Care Delivery
National coverage analyses for NCI clinical trials: A pilot project to reduce participation barriers
- Journal / Conference
- J Clin Oncol 35, 2017 (suppl; abstr 1541); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
- Year
- 2017
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217